110 related articles for article (PubMed ID: 4778374)
1. Plasma 25-hydroxycholecalciferol in chronic renal failure.
Bayard F; Bec P; Ton That H; Louvet JP
Eur J Clin Invest; 1973 Dec; 3(6):447-50. PubMed ID: 4778374
[No Abstract] [Full Text] [Related]
2. Vitamin-D deficiency in the osteomalacia of chronic renal failure.
Eastwood JB; Stamp TC; Harris E; de Wardener HE
Lancet; 1976 Dec; 2(7997):1209-11. PubMed ID: 63038
[TBL] [Abstract][Full Text] [Related]
3. Clinical effects of 25-hydroxycholecalciferol in patients with chronic renal failure.
Matsushita Y; Hasegawa K; Otomo S; Morii H; Okamoto T
J Nutr Sci Vitaminol (Tokyo); 1977; 23(3):257-61. PubMed ID: 915557
[No Abstract] [Full Text] [Related]
4. 25-Hydroxycholecaliferol and fractures of the proximal.
Lund B; Sorensen OH; Christensen AB
Lancet; 1975 Aug; 2(7929):300-2. PubMed ID: 50509
[TBL] [Abstract][Full Text] [Related]
5. Controlled trial of 1apha-hydroxycholecalciferol in chronic renal failure.
Tougaard L; Sorensen E; Brochner-Mortensen J; Christensen MS; Rodbro P; Sorensen AW
Lancet; 1976 May; 1(7968):1044-7. PubMed ID: 57451
[TBL] [Abstract][Full Text] [Related]
6. Serum 25-hydroxyvitamin D in patients with chronic renal disease.
Pietrek J; Kokot F
Eur J Clin Invest; 1977 Aug; 7(4):283-7. PubMed ID: 408149
[No Abstract] [Full Text] [Related]
7. Hypoparathyroidism: a possible cause of osteomalacia .
Drezner MK; Neelon FA; Jowsey J; Lebovitz HE
J Clin Endocrinol Metab; 1977 Jul; 45(1):114-22. PubMed ID: 874058
[TBL] [Abstract][Full Text] [Related]
8. Effects of 25-hydroxycholecalciferol on calcium metabolism in chronic renal failure.
Letteri JM; Kleinman LM; Ellis KN; Caselnova R; Akhtar M; Cohn SH
Adv Exp Med Biol; 1977; 81():591-601. PubMed ID: 899943
[No Abstract] [Full Text] [Related]
9. [Parathyroid hormone values in patients on chronic dialysis treatment].
Mushmov D; Milkov V; Kiriakov Z; Zakharieva B
Vutr Boles; 1986; 25(3):59-62. PubMed ID: 3765580
[TBL] [Abstract][Full Text] [Related]
10. 1-year controlled trial of 1 alpha-hydroxycholecalciferol in patients on maintenance hemodialysis.
Shimamatsu K; Maeda T; Harada A; Nishitani H; Onoyama K; Fujimi S; Omae T
Nephron; 1981; 28(2):70-5. PubMed ID: 7027062
[TBL] [Abstract][Full Text] [Related]
11. 1,25-dihydroxycholecalciferol in patients with chronic renal failure.
Henderson RG; Ledingham JG; Norman AW; Oliver DO; Preston C; Russell RG; Small DG; Smith R; Warner GT; Woods CG
Proc Eur Dial Transplant Assoc; 1973; 10(0):202-9. PubMed ID: 4802654
[No Abstract] [Full Text] [Related]
12. The contrasting effects on bone histology of vitamin D and of calcium carbonate in the osteomalacia of chronic renal failure.
Eastwood JB; Bordier PJ; Clarkson EM; Tun Chot S; de Wardener HE
Clin Sci Mol Med; 1974 Jul; 47(1):23-42. PubMed ID: 4854694
[No Abstract] [Full Text] [Related]
13. [The effect of 1alpha-hydroxycholecalciferol on the abnormal calcium metabolism in hemodialysis patients.--Studies on patients showing low serum calcium and high alkaline phosphatase (author's transl)].
Asai K; Ohkura T; Sakamoto N; Kawahara H; Yamazaki C
Nihon Jinzo Gakkai Shi; 1978 Sep; 20(9):967-77. PubMed ID: 713173
[No Abstract] [Full Text] [Related]
14. [Osteomalacia and anticonvulsant therapy: serum assay of 25 hydroxy D in an epileptic population (author's transl) (proceedings)].
Ribot C; Geraud G; Castignol M; Dero M; Geraud J; Boulard C
Ann Endocrinol (Paris); 1976; 37(6):483-4. PubMed ID: 1026169
[No Abstract] [Full Text] [Related]
15. [Hyperphosphoremia states in hemodialysed patients with chronic renal insufficiency].
Duchatelle P; Lelievre G; Tacquet A
Lille Med; 1973 Feb; 18(2):116-24. PubMed ID: 4732957
[No Abstract] [Full Text] [Related]
16. [Long-term treatment of secondary hyperparathyroidism in the chronic hemodialysis patient with 1,25-(OH)2D3].
Giachino G; Giacchino F; Jeantet A; Del Piano A; Garetto A; Pellerey M; Piccoli G
Minerva Med; 1985 Mar; 76(9-10):407-14. PubMed ID: 2984605
[No Abstract] [Full Text] [Related]
17. Vitamin-D status in long-stay geriatric patients.
Corless D; Boucher BJ; Cohen RD; Beer M; Gupta SP
Lancet; 1975 Jun; 1(7922):1404-6. PubMed ID: 49563
[TBL] [Abstract][Full Text] [Related]
18. Comparison of 1 alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in the treatment of renal osteodystrophy: greater effect of 25-hydroxycholecalciferol on bone mineralization.
Fournier A; Bordier P; Gueris J; Sebert JL; Marie P; Ferrière C; Bedrossian J; DeLuca HF
Kidney Int; 1979 Feb; 15(2):196-204. PubMed ID: 513484
[No Abstract] [Full Text] [Related]
19. Bone disease and hyperparathyroidism in chronic renal failure: the effect of 1alpha-hydroxyvitamin D3.
Peacock M; Aaron JE; Walker GS; Davison AM
Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():73s-81s. PubMed ID: 606428
[No Abstract] [Full Text] [Related]
20. Serum 25-hydroxycalciferol concentrations in normal subjects and in haemodialysed patients with chronic renal failure.
Kálmán J; Gömöri A; Juhász J; Szücs J
Int Urol Nephrol; 1980; 12(3):257-62. PubMed ID: 7251291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
